Stay Curious

SIGN UP FOR OUR WEEKLY NEWSLETTER AND UNLOCK ONE MORE ARTICLE FOR FREE.

Sign Up

VIEW OUR Privacy Policy


Discover Magazine Logo

WANT MORE? KEEP READING FOR AS LOW AS $1.99!

Subscribe

ALREADY A SUBSCRIBER?

FIND MY SUBSCRIPTION
Advertisement

Developing A Drug To Identify And Target Tricky Cancer Cells

Cancer cells are extremely adept at flying under the immune system’s radar. But recent research points to a way of making certain cancers more targetable.

Credit: Design_Cells/Shutterstock

Newsletter

Sign up for our email newsletter for the latest science news

Sign Up

Cancer is a tricky disease to tackle. The simplicity and universality of the name belies the breadth and diversity of cancers out there. They attack every inch of the body in a myriad of ways, using a variety of tactics and DNA they can edit on the fly to evade capture and bypass our body’s defenses.

One commonality between them, though, is that they all come from within (apart from a few rare, contagious cancers like the Tasmanian devil’s facial tumor disease). They’re built from your cells. And that’s one of the greatest obstacles to treating cancers with broad-spectrum immunotherapies: It’s really difficult for your immune system to distinguish cancer cells from regular cells.

Read More: Eating Ice Cream During Chemotherapy Could Help Some Side Effects

“People have been looking for what we call cancer-specific antigens” for a very long time, says Kevan Shokat, who runs a cellular and molecular ...

Stay Curious

JoinOur List

Sign up for our weekly science updates

View our Privacy Policy

SubscribeTo The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Subscribe
Advertisement

0 Free Articles